Xilio Therapeutics, Inc.
USD8.20
-0.05 (-0.61%)
CEO
Rene Russo
IPO Date
2021-10-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.34
Prev. Close
$8.25
Day Low
$8.18
Day High
$8.39
52W Low
$6.47
52W High
$12.74
Market Cap
$0.05B
Volume
0.03M
| 0 |
| $0.00 |
| 30 Mar 2026 | Shannon James Samuel | director | P-Purchase | Acquired | 5,000 | $8.79 |
| 17 Feb 2026 | GILEAD SCIENCES, INC. | 10 percent owner | P-Purchase | Acquired | 3,739,000 | $0.00 |
| 5 Jan 2026 | Luptakova Katarina | CHIEF MEDICAL OFFICER | A-Award | Acquired | 451,885 | $0.84 |
| 5 Jan 2026 | Luptakova Katarina | CHIEF MEDICAL OFFICER | M-Exempt | Disposed | 16,625 | $0.00 |
| 5 Jan 2026 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | M-Exempt | Acquired | 5,000 | $0.00 |
| 5 Jan 2026 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | S-Sale | Disposed | 1,826 | $0.64 |
| 5 Jan 2026 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | A-Award | Acquired | 95,221 | $0.84 |
| 5 Jan 2026 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | M-Exempt | Disposed | 5,000 | $0.00 |